Malgorzata Kasztan

Dr. Malgorzata Kasztan


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2019 in Blood Advances
Verified
Journal Article
Closed access
PDF file
MKMalgorzata Kasztan
Malgorzata Kasztan
BFBrandon M. Fox
Brandon M. Fox
JLJeffrey D. Lebensburger
Jeffrey D. Lebensburger
KHKelly A. Hyndman
Kelly A. Hyndman
JSJoshua S. Speed
Joshua S. Speed
DPDavid M. Pollock
David M. Pollock
Key Points: In HbSS mice, hyperfiltration predicts long-term kidney damage and tubular injury occurs prior to glomerular damage. Sex contributes to the progression of kidney injury in HbSS mice.

13 April 2023 in Blood
Verified
Journal Article
Open access
PDF file
ESErica M. Sparkenbaugh
Erica M. Sparkenbaugh
MHMichael W. Henderson
Michael W. Henderson
MMMegan Miller-Awe
Megan Miller-Awe
CAChristina Abrams
Christina Abrams
AIAnton Ilich
Anton Ilich
RPRafal Pawlinski
Rafal Pawlinski
A hypercoagulable state, chronic inflammation, and increased risk of venous thrombosis and stroke are prominent features in patients with sickle cell disease (SCD). Coagulation factor XII (FXII) triggers activation of the contact system that is known to be involved in both thrombosis and inflammation, but not in physiological hemostasis. Therefore, we investigated whether FXII contributes to the prothrombotic and inflammatory complications associated with SCD. We found that when compared with healthy controls, patients with SCD exhibit increased circulating biomarkers of FXII activation that are associated with increased activation of the contact pathway. We also found that FXII, but not tissue factor, contributes to enhanced thrombin generation and systemic inflammation observed in sickle cell mice challenged with tumor necrosis factor α. In addition, FXII inhibition significantly reduced experimental venous thrombosis, congestion, and microvascular stasis in a mouse model of SCD. Moreover, inhibition of FXII attenuated brain damage and reduced neutrophil adhesion to the brain vasculature of sickle cell mice after ischemia/reperfusion induced by transient middle cerebral artery occlusion. Finally, we found higher FXII, urokinase plasminogen activator receptor, and αMβ2 integrin expression in neutrophils of patients with SCD compared with healthy controls. Our data indicate that targeting FXII effectively reduces experimental thromboinflammation and vascular complications in a mouse model of SCD, suggesting that FXII inhibition may provide a safe approach for interference with inflammation, thrombotic complications, and vaso-occlusion in patients with SCD.

1 May 2019 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Open access
PDF file
KHKelly A. Hyndman
Kelly A. Hyndman
MKMalgorzata Kasztan
Malgorzata Kasztan
LMLuciano D. Mendoza
Luciano D. Mendoza
SMSureena Monteiro-Pai
Sureena Monteiro-Pai
Deranged histone deacetylase (HDAC) activity causes uncontrolled proliferation, inflammation, fibrosis, and organ damage. It is unclear whether deranged HDAC activity results in acute kidney injury in the renal hypoperfusion model of bilateral ischemia-reperfusion injury (IRI) and whether in vivo inhibition is an appropriate therapeutic approach to limit injury. Male mice were implanted with intraperitoneal osmotic minipumps containing vehicle, the class I HDAC inhibitor, MS275, or the pan-HDAC inhibitor, trichostatin A (TSA), 3 days before sham/bilateral IRI surgery. Kidney cortical samples were analyzed using histological, immunohistochemical, and Western blotting techniques. HDAC-dependent proliferation rate was measured in immortalized rat epithelial cells and primary mouse or human proximal tubule (PT) cells. There were dynamic changes in cortical HDAC localization and abundance following IRI including a fourfold increase in HDAC4 in the PT. HDAC inhibition resulted in a significantly higher plasma creatinine, increased kidney damage, but reduced interstitial fibrosis compared with vehicle-treated IRI mice. HDAC-inhibited mice had reduced interstitial α-smooth muscle actin, fibronectin expression, and Sirius red-positive area, suggesting that IRI activates HDAC-mediated fibrotic pathways. In vivo proliferation of the kidney epithelium was significantly reduced in TSA-treated, but not MS275-treated, IRI mice, suggesting class II HDACs mediate proliferation. Furthermore, HDAC4 activation increased proliferation of human and mouse PTs. Kidney HDACs are activated during IRI with isoform-specific expression patterns. Our data point to mechanisms whereby IRI activates HDACs resulting in fibrotic pathways but also activation of PT proliferation and repair pathways. This study demonstrates the need to develop isoform-selective HDAC inhibitors for the treatment of renal hypoperfusion-induced injury.

17 January 2020 in Blood Advances
Verified
Journal Article
Open access
PDF file
MKMalgorzata Kasztan
Malgorzata Kasztan
IAInmaculada Aban
Inmaculada Aban
SHSuraj P. Hande
Suraj P. Hande
DPDavid M. Pollock
David M. Pollock
JLJeffrey D. Lebensburger
Jeffrey D. Lebensburger

15 July 2019 in Clinical Science
Verified
Journal Article
Closed access
PDF file
MKMalgorzata Kasztan
Malgorzata Kasztan
DPDavid M. Pollock
David M. Pollock
Hyperfiltration, highly prevalent early in sickle cell disease (SCD), is in part driven by an increase in ultrafiltration coefficient (Kf). The increases in Kf may be due to enlarged filtration surface area and/or increased glomerular permeability (Palb). Previous studies have demonstrated that endothelin-1 (ET-1) contributes to Palb changes in models of diabetes and SCD. Thus, we performed longitudinal studies of renal function to determine the relationship between ET-1 and glomerular size and Palb that may contribute to hyperfiltration in humanized sickle cell (HbSS) and control (HbAA) mice 8 to 32 weeks of age. HbSS mice were characterized by significant increases in plasma and glomerular ET-1 expression in both sexes although this increase was significantly greater in males. HbSS glomeruli of both males and females presented with a progressive and significant increase in glomerular size, volume, and Kf. During the onset of hyperfiltration, plasma and glomerular ET-1 expression were associated with a greater increase in glomerular size and Kf in HbSS mice, regardless of sex. The pattern of Palb augmentation during the hyperfiltration was also associated with an increase in glomerular ET-1 expression, in both male and female HbSS mice. However, the increase in Palb was significantly greater in males and delayed in time in females. Additionally, selective endothelin A (ETA) receptor antagonist prevented hyperfiltration in HbSS, regardless of sex. These results suggest that marked sex disparity in glomerular hyperfiltration may be driven, in part, by ET-1-dependent ultra-structural changes in filtration barrier components contributing to glomerular hyperfiltration in HbSS mice.

23 June 2020 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
ESErica M. Sparkenbaugh
Erica M. Sparkenbaugh
MKMalgorzata Kasztan
Malgorzata Kasztan
MHMichael W. Henderson
Michael W. Henderson
PEPatrick Ellsworth
Patrick Ellsworth
PDParker Ross Davis
Parker Ross Davis
RPRafal Pawlinski
Rafal Pawlinski